SciELO - Scientific Electronic Library Online

 
vol.32 número4El papel de los biosimilares en la enfermedad inflamatoria intestinal: una realidad en nuestro paísElastografía en tiempo real (supersonic): comportamiento de la prueba en sujetos sanos de Bogotá índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista colombiana de Gastroenterología

versión impresa ISSN 0120-9957

Resumen

TRIANA, Juan José et al. Disease Burden of Gastric Cancer in Disability-Adjusted Life Years in Colombia. Rev Col Gastroenterol [online]. 2017, vol.32, n.4, pp.326-331. ISSN 0120-9957.  https://doi.org/10.22516/25007440.175.

Objective:

Gastric cancer is the second most common cause of cancer death and the fifth most common neoplasm in the world. In Colombia, it is the leading cause of cancer mortality. The annual incidence and mortality are 16.3/100,000 and 14.2/100,000 inhabitants respectively. The aim of this study was to estimate the disease burden in Colombia as measured in disability-adjusted life years (DALYs).

Methods:

This study focuses on prevalence in 2014. To estimate prevalence, a search was made in the registries of the Social Protection Information System (SISPRO) and the National Administrative Department of Statistics (DANE). The average duration of cases and estimated survival were obtained from the local literature. DALYs were calculated by adding the years of life lost due to premature death (YLLs) and years of life lived with disability (YLD) according to the methodology of the World Health Organization (WHO).

Results:

Prevalences estimated for five years in the population older than 15 years were 40.9/100,000 for women and 62.5/100,000 for men. The total DALY was 293,418, with a rate of 623/100,000 inhabitants; 97.4% correspond to YLL. The YLD and YLL for Colombia were 16/100,000 and 607/100,000, respectively.

Conclusions:

Data obtained from SISPRO and DANE estimate a high disease burden in Colombia. It is necessary to implement early cancer detection strategies to reduce the burden of disease and improve patient prognosis.

Palabras clave : Gastric neoplasms; cost of illness; prevalence; factual databases.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )